enVVeno Medical (NVNO) Receivables (2017 - 2022)

enVVeno Medical's quarterly Receivables came in at $38000.0 in Q2 2022, up 43.32% quarter-over-quarter from $26515.0 in Q1 2019.

enVVeno Medical has reported Receivables for 4 years, with the latest figure at $38000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Receivables changed N/A year-over-year to $38000.0; the trailing twelve-month figure through Jun 2022 stood at $38000.0 (changed N/A YoY), and the FY2018 full-year result was $32022.0, down 8.98% from the prior year.
  • Receivables for Q2 2022 stood at $38000.0, up from $26515.0 in the prior quarter.
  • The five-year high for Receivables was $38000.0 in Q2 2022, with the low at $26515.0 in Q1 2019.
  • Average Receivables over 3 years is $30712.6, with a median of $28964.0 recorded in 2018.
  • Peak annual rise in Receivables reached 8.98% in 2018, while the deepest fall reached 8.98% in 2018.
  • Tracing NVNO's Receivables over 3 years: stood at $32022.0 in 2018, then fell by 17.2% to $26515.0 in 2019, then soared by 43.32% to $38000.0 in 2022.
  • The last three Receivables figures came in at $38000.0 (Q2 2022), $26515.0 (Q1 2019), and $32022.0 (Q4 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.21 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.36 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.15 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 973.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.82 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.11 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 4.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.09 Bn
10 enVVeno Medical 6.99 Mn 6.99 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 38,000.00
Mar 31, 2019 26,515.00
Dec 31, 2018 32,022.00
Sep 30, 2018 28,062.00
Jun 30, 2018 28,964.00
Dec 31, 2017 35,181.00